Patent US4849418A successfully refreshed from Google Patents.
US4849418A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Transdermally absorbable water-containing preparations of arylpropionic acid derivatives and process for preparing same
Assignee: Dolorgiet Beteiligungs GmbH
•
Filing: 1987-11-16
•
Granted: 1989-07-18
•
Expires: 2007-11-16
Abstract
Abstract Transdermally absorbable water-containing preparations of therapeutically active arylpropionic acid derivatives comprises 1 to 15% by weight of such active ingredient, from 10 to 40% by weight of polyoxyethylene polyoxypropylene copolymers, from 10 to 50% by weight of one or more physiologically acceptable organic solvents, optionally up to 1% by weight of preservatives, colorants and/or perfumes, and at least 10% by weight of water. From polyoxyethylene polyoxypropylene copolymers having a relative molecular weight of more than 6,000 there may also be prepared gels, if certain ratios of amounts are chosen.
Inventors
- 👤 Manfred Lohner
- 👤 Hans H. Wagener
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 19:00
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0014; A61K31/00; A61K31/185; A61K31/19; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K47/20; A61K47/26; A61P; A61P25/00; A61P25/04; A61P29/00
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
66 words
A transdermally absorbable water-containing analgesic, antirheumatic, antiinflammatory, gel preparation comprising from 5 to 10% of ibuprofen, from 10 to 40% by weight of polyoxyethylene polyoxypropylene copolymers, from 10 to 50% by weight of one or more physiologically acceptable organic solvents, optionally up to 1% by weight of preservatives, colorants and/or perfumes, and at least 10% by weight of water, said gel being free of neutralizing bases.
Claim 2
Dependent Claim
66 words
A transdermally absorbable water-containing analgesic, antirheumatic, antiinflammatory, gel preparation comprising from 5 to 10% of ibuprofen, from 10 to 40% by weight of polyoxyethylene polyoxypropylene copolymers, from 10 to 50% by weight of one or more physiologically acceptable organic solvents, optionally up to 1% by weight of preservatives, colorants and/or perfumes, and at least 10% by weight of water, said gel being free of neutralizing bases.
Claim 3
Dependent Claim
33 words
A preparation according to claim 1, which comprises from 15 to 32% by weight of polyoxyethylene polyoxypropylene copolymers, and from 17 to 44% by weight of one or more physiologically acceptable organic solvents.
Claim 4
Dependent Claim
20 words
A preparation according to claim 1, wherein the polyoxyethylene polyoxypropylene copolymers have relative molecular weights of from 1,000 to 13,000.
Claim 5
Dependent Claim
22 words
A preparation according to claim 1, characterized in that the polyoxyethylene polyoxypropylene copolymers have relative molecular weights of from 6,000 to 13,000.
Claim 6
Dependent Claim
59 words
A preparation according to claim 1, characterized in that as the physiologically acceptable organic solvents there are used dimethyl sulfoxide or mono-, di- or tri-hydroxy straight-chain, branched or cyclic alcohols having from 2 to 6 carbon atoms in the carbon backbone into which 0 to 2 oxygen atoms have been inserted, or polyoxyalkylene fatty alcohol ethers or mixtures thereof.
Claim 7
Dependent Claim
27 words
A preparation according to claim 5, characterized in that there are used as solvents ethanol, isopropanol, 1,2-propanediol, glycerol, isosorbide, dimethylisosorbide, polyoxyethylene-(4)-lauryl ether, polyoxypropylene-(15)-stearyl ether or mixtures thereof.
Claim 8
Dependent Claim
35 words
A preparation according to claim 1, characterized in that it further comprises up to 2% by weight of a blood circulation-promoting or rubefacient substance selected from the group consisting of benzyl nicotinate and a salicylate.
Claim 9
Dependent Claim
18 words
A preparation according to claim 7, characterized in that the blood circulation-promoting or rubefacient substance is benzyl nicotinate.
Claim 10
Dependent Claim
18 words
A preparation according to claim 7, characterized in that the blood circulation-promoting or rubefacient substance is a salicylate.
Claim 11
Dependent Claim
92 words
A process for making a transdermally absorbable water-containing antirheumatic, anti-inflammatory, analgesic gel characterized in that a mixture comprising from 5 to 10% by weight of ibuprofen as an active ingredient, from 10 to 40% by weight of polyoxyethylene polyoxypropylene copolymers, from 10 to 50% by weight of one or more physiologically acceptable organic solvents, optionally up to 1% by weight of preservatives, colorants and/or perfumes, and at least 10% by weight of water are heated with stirring at from 40° C. to 90° C. in the absence of neutralizing bases then cooled.
Claim 12
Dependent Claim
92 words
A process for making a transdermally absorbable water-containing antirheumatic, anti-inflammatory, analgesic gel characterized in that a mixture comprising from 5 to 10% by weight of ibuprofen as an active ingredient, from 10 to 40% by weight of polyoxyethylene polyoxypropylene copolymers, from 10 to 50% by weight of one or more physiologically acceptable organic solvents, optionally up to 1% by weight of preservatives, colorants and/or perfumes, and at least 10% by weight of water are heated with stirring at from 40° C. to 90° C. in the absence of neutralizing bases then cooled.
Claim 13
Dependent Claim
56 words
The process for making a gel according to claim 10, characterized in that from 15 to 32% by weight of polyoxyethylene polyoxypropylene copolymers and from 17 to 44% by weight of one or more physiologically acceptable organic solvents are heated at from 80° C. to 90° C. in the absence of neutralizing bases and then cooled.
Claim 14
Dependent Claim
55 words
The process according to claim 10, characterized in that, as the physiologically acceptable organic solvents there are used dimethyl sulfoxide or mono-, di- or trihydroxy straight-chain, branched or cyclic alcohols having from 2 to 6 carbon atoms and 0 to 2 oxygen atoms in the carbon backbone or polyoxyalkylene fatty alcohol ethers or mixtures thereof.
Claim 15
Dependent Claim
27 words
The process according to claim 12, characterized in that there are used as solvents ethanol, isopropanol, 1,2-propanediol, glycerol, isosorbide, dimethylisosorbide, polyoxyethylene-(4)-lauryl ether, polyoxypropylene-(15)-stearyl ether or mixtures thereof.
Claim 16
Dependent Claim
37 words
The process according to claim 10, characterized in that the mixture further comprises up to 2% by weight of a blood circulation-promoting or rubefacient substance selected from the group consisting of a benzyl nicotinate and a salicylate.
Claim 17
Dependent Claim
18 words
The process according to claim 14, characterized in that the blood circulation-promoting or rubefacient substance is benzyl nicotinate.
Claim 18
Dependent Claim
18 words
The process according to claim 14, characterized in that the blood circulation-promoting or rubefacient substance is a salicylate.
References Cited (Backward Citations)
US3740421A
Cited
DE1617480A1
Cited
DE2708152A1
Cited
EP0072462A2
Cited
US4555524A
Cited
US4533546A
Cited
US4511563A
Cited
US4534980A
Cited
EP0178436A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-07-17 | 1993-01-16 | 1993-07-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-07-17 | 1997-01-16 | 1997-07-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-07-17 | 2001-01-16 | 2001-07-18 | $7700.00 | Window Closed / Lapsed |